CIK: 0001582844
Total reported value
$141.8M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CLDX | Celldex Therapeutics INC | Stock-Other | 7.76% | — | +5.34% | |
| 2 | SG7 | Sage Therapeutics INC | Stock-Other | 6.02% | — | +13.69% | |
| 3 | KURA | Kura Oncology INC | Stock-Other | 5.67% | — | -34.48% | |
| 4 | LRMR | Larimar Therapeutics INC | Stock-Other | 5.03% | — | +3.99% | |
| 5 | ✓ | Mersana Therapeutics INC | Stock-Other | 5.03% | — | +3.97% | |
| 6 | CMPS | Compass Pathways PLC | Stock-Other | 4.14% | — | -18.21% | |
| 7 | VTGNUSD | Vistagen Therapeutics INC | Stock-Other | 3.96% | — | — | |
| 8 | ✓ | Athira Pharma INC | Stock-Other | 3.66% | — | +8.41% | |
| 9 | IMVT | Immunovant INC | Stock-Other | 3.56% | — | +13.40% | |
| 10 | TREUR | Trillium Therapeutics INC | Stock-Other | 3.21% | — | -5.86% | |
| 11 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 2.90% | — | +36.95% | |
| 12 | ETNBGBP | 89bio INC | Stock-Other | 2.88% | — | +4.05% | |
| 13 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 2.82% | — | +93.36% | |
| 14 | APLSUSD | Apellis Pharmaceuticals INC | Stock-Other | 2.60% | — | — | |
| 15 | ✓ | Bcls Acquisition CORP | Stock-Other | 2.55% | — | — | |
| 16 | SURFUSD | Surface Oncology INC | Stock-Other | 2.51% | — | -8.13% | |
| 17 | ✓ | Gyre Therapeutics INC Com | Stock-Other | 2.33% | — | -9.37% | |
| 18 | OPHTEUR | Iveric Bio INC | Stock-Other | 2.28% | — | +51.09% | |
| 19 | FULC | Fulcrum Therapeutics INC | Stock-Other | 2.17% | — | +78.90% | |
| 20 | REPL | Replimune Group INC | Stock-Other | 2.15% | — | — | |
| 21 | IOVA | Iovance Biotherapeutics INC | Stock-Other | 2.08% | — | -47.68% | |
| 22 | CNCEEUR | Concert Pharmaceuticals INC | Stock-Other | 1.85% | — | +79.17% | |
| 23 | ALT | Altimmune INC | Stock-Other | 1.78% | — | -15.92% | |
| 24 | RNAGBP | Avidity Biosciences INC | Stock-Other | 1.71% | — | +4.77% | |
| 25 | ✓ | Jiya Acquisition CORP | Stock-Other | 1.58% | — | — | |
| 26 | STOK | Stoke Therapeutics INC | Stock-Other | 1.56% | — | — | |
| 27 | ✓ | Veralto CORP | Stock-Other | 1.39% | — | — | |
| 28 | ✓ | Health Sciences Acq CORP 2 | Stock-Other | 1.37% | — | — | |
| 29 | ✓ | Avadel Pharmaceuticals PLC | Stock-Other | 1.28% | — | — | |
| 30 | CRISEUR | Curis INC | Stock-Other | 1.18% | — | — | |
| 31 | BHVN | Biohaven Ltd. | Stock-Other | 1.17% | — | — | |
| 32 | PRAX | Praxis Precision Medicines, Inc. | Stock-Other | 1.13% | — | — | |
| 33 | ✓ | Rapt Therapeutics INC | Stock-Other | 1.13% | — | -12.67% | |
| 34 | RLMD | Relmada Therapeutics INC | Stock-Other | 1.05% | — | -56.68% | |
| 35 | CCCC | C4 Therapeutics INC | Stock-Other | 0.99% | — | — | |
| 36 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 0.98% | — | — | |
| 37 | CLSDUSD | Clearside Biomedical INC | Stock-Other | 0.93% | — | +103.25% | |
| 38 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 0.52% | — | -56.86% | |
| 39 | ✓ | Oncorus INC | Stock-Other | 0.47% | — | — | |
| 40 | ALDX | Aldeyra Therapeutics INC | Stock-Other | 0.36% | — | -88.31% | |
| 41 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 0.33% | — | -73.33% | |
| 42 | ✓ | CYCLACEL PHARMACE 6percent PFDCONV | Stock-Other | 0.32% | — | — | |
| 43 | RCKT | Rocket Pharmaceuticals INC | Stock-Other | 0.30% | — | — | |
| 44 | PMVP | Pmv Pharmaceuticals INC | Stock-Other | 0.25% | — | — | |
| 45 | WVE | Wave Life Sciences Ltd. | Stock-Other | 0.23% | — | — | |
| 46 | FDMT | 4d Molecular Therapeutics In | Stock-Other | 0.23% | — | — | |
| 47 | ANNX | Annexon INC | Stock-Other | 0.17% | — | -77.27% | |
| 48 | ✓ | Stock-Other | 0.14% | — | -62.96% | ||
| 49 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 0.13% | — | -73.33% | |
| 50 | ✓ | Panacea Acquisition CORP | Stock-Other | 0.08% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SG7 | Sage Therapeutics INC | +2.3% | +13.69% | Add |
| 2 | SNDX | Syndax Pharmaceuticals INC | +1.9% | +93.36% | Add |
| 3 | ✓ | Athira Pharma INC | +1.8% | +8.41% | Add |
| 4 | ARWR | Arrowhead Pharmaceuticals In | +1.7% | +36.95% | Add |
| 5 | ✓ | Mersana Therapeutics INC | +1.7% | +3.97% | Add |
| 6 | LRMR | Larimar Therapeutics INC | +1.6% | +3.99% | Add |
| 7 | CLDX | Celldex Therapeutics INC | +1.5% | +5.34% | Add |
| 8 | FULC | Fulcrum Therapeutics INC | +1.4% | +78.90% | Add |
| 9 | APLSUSD | Apellis Pharmaceuticals INC | +1.2% | — | Unchanged |
| 10 | IMVT | Immunovant INC | +1.2% | +13.40% | Add |
| 11 | OPHTEUR | Iveric Bio INC | +1.1% | +51.09% | Add |
| 12 | CNCEEUR | Concert Pharmaceuticals INC | +1.1% | +79.17% | Add |
| 13 | CLSDUSD | Clearside Biomedical INC | +0.7% | +103.25% | Add |
| 14 | ✓ | Veralto CORP | +0.6% | — | Unchanged |
| 15 | ✓ | Gyre Therapeutics INC Com | +0.6% | -9.37% | Trim |
| 16 | SURFUSD | Surface Oncology INC | +0.5% | -8.13% | Trim |
| 17 | CMPS | Compass Pathways PLC | +0.4% | -18.21% | Trim |
| 18 | ✓ | Avadel Pharmaceuticals PLC | +0.3% | — | Unchanged |
| 19 | AXSM | Axsome Therapeutics INC | -0.3% | -73.33% | Trim |
| 20 | XENE | Xenon Pharmaceuticals INC | -0.6% | -73.33% | Trim |
| 21 | ALT | Altimmune INC | -0.7% | -15.92% | Trim |
| 22 | ANNX | Annexon INC | -0.7% | -77.27% | Trim |
| 23 | IOVA | Iovance Biotherapeutics INC | -0.7% | -47.68% | Trim |
| 24 | ✓ | Rapt Therapeutics INC | -1% | -12.67% | Trim |
| 25 | CBAYUSD | Cymabay Therapeutics INC | -1% | -56.86% | Trim |
| 26 | RLMD | Relmada Therapeutics INC | -1.8% | -56.68% | Trim |
| 27 | KURA | Kura Oncology INC | -2.4% | -34.48% | Trim |
| 28 | ALDX | Aldeyra Therapeutics INC | -3% | -88.31% | Trim |
| 29 | IMMU | Immunomedics INC | — | EXIT | Sold out |
| 30 | XBI | Ss Spdr S&p Biotech ETF | — | EXIT | Sold out |
| 31 | VTGNUSD | Vistagen Therapeutics INC | — | NEW | New buy |
| 32 | ✓ | Bcls Acquisition CORP | — | NEW | New buy |
| 33 | REPL | Replimune Group INC | — | NEW | New buy |
| 34 | CYTK | Cytokinetics INC | — | EXIT | Sold out |
| 35 | ✓ | Lifesci Acquisition CORP | — | EXIT | Sold out |
| 36 | SELBUSD | Cartesian Therapeutics INC | — | EXIT | Sold out |
| 37 | ✓ | Jiya Acquisition CORP | — | NEW | New buy |
| 38 | STOK | Stoke Therapeutics INC | — | NEW | New buy |
| 39 | CRDF | Cardiff Oncology INC | — | EXIT | Sold out |
| 40 | CRISEUR | Curis INC | — | NEW | New buy |
| 41 | BHVN | Biohaven Ltd. | — | NEW | New buy |
| 42 | PRAX | Praxis Precision Medicines, Inc. | — | NEW | New buy |
| 43 | CCCC | C4 Therapeutics INC | — | NEW | New buy |
| 44 | MDGL | Madrigal Pharmaceuticals INC | — | NEW | New buy |
| 45 | ✓ | Panacea Acquisition CORP | — | EXIT | Sold out |
| 46 | BCRX | Biocryst Pharmaceuticals INC | — | EXIT | Sold out |
| 47 | ✓ | Oncorus INC | — | NEW | New buy |
| 48 | ✓ | CYCLACEL PHARMACE 6percent PFDCONV | — | NEW | New buy |
| 49 | RCKT | Rocket Pharmaceuticals INC | — | NEW | New buy |
| 50 | ✓ | Unum Therapeutics INC | — | EXIT | Sold out |